Medical University of South Carolina Investigational Drug Services is a clinical research site located in Charleston, South Carolina, United States 29425.
Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Medical University of South Carolina Investigational Drug Services has participated in 6 clinical trials with 2 currently active.
Therapeutic areas: Sickle Cell Disease, Dermatitis, Atopic, COVID-19 Infection.
Sponsors: Pfizer, Bristol-Myers Squibb, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in South Carolina · View every site in Charleston
Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Medical University of South Carolina Investigational Drug Services has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Medical University of South Carolina Investigational Drug Services has 6 clinical trials on record, with 2 currently active. Their work covers Sickle Cell Disease, Dermatitis, Atopic, COVID-19 Infection.
Medical University of South Carolina Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.